Lv4
480 积分 2023-08-30 加入
Physiologically Based Pharmacokinetic Model‐Informed Drug Development for Polatuzumab Vedotin: Label for Drug‐Drug Interactions Without Dedicated Clinical Trials
3天前
已完结
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
5天前
已完结
EDG-7500, A First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, And Pharmacokinetics In Healthy Adults
24天前
已完结
Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis
1个月前
已完结
Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
1个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
2个月前
已完结
Aficamten in non‐obstructive hypertrophic cardiomyopathy: Unlocking new horizons?
6个月前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
6个月前
已完结
Blood eosinophil count as predictor of asthma exacerbation. A meta‐analysis
7个月前
已完结
A review of plant-based expression systems as a platform for single-domain recombinant antibody production
7个月前
已完结
皖公网安备34019202002308
